GLP-1 Access by StateFL

GLP-1 Weight Loss Medications in Florida

Navigate GLP-1 access in Florida — from the coverage gap to the thriving telehealth and weight loss clinic market.

Telehealth Prescribing

Allowed

Restrictions

Florida enacted SB 1794 (2019) establishing telehealth regulations. Providers must hold a Florida license or register as out-of-state telehealth providers. Florida requires real-time audio-video for initial consultations but allows telephone follow-ups for established patients.

Prescribing Rules

GLP-1 medications can be prescribed via telehealth in Florida without an in-person visit. Florida law permits prescribing non-controlled medications through telehealth after establishing a patient-provider relationship via synchronous video. Florida has a large out-of-state telehealth provider registration system that expands provider availability.

Insurance Coverage

Medicaid Coverage

Limited / Not expanded

Prior Authorization

Typically required

Major Insurers

Florida Blue (BCBS)UnitedHealthcareAetnaCignaHumanaMolina Healthcare

Florida has not expanded Medicaid. Traditional Medicaid covers only very low-income parents, pregnant women, and disabled individuals. This leaves roughly 800,000 Floridians in the coverage gap. Commercial insurance through the marketplace or employers is the primary coverage pathway. Florida has the largest Medicare population in the country, and Medicare Part D plans are increasingly covering GLP-1 medications.

Cost Breakdown

Brand Name

$900-$1400

per month, without insurance

Compounded

Available

$150-$400

per month

Top Providers in Florida

Hims & Hers

Telehealth

Major presence in Florida; ships compounded semaglutide across the state rapidly.

Cleveland Clinic Florida (Weston)

In-Person

Comprehensive weight management program at Cleveland Clinic Weston campus in South Florida.

Noom

Telehealth

Combines GLP-1 prescribing with behavioral change programs for Florida residents.

MD Live / Evernorth

Telehealth

Florida-based telehealth company (Sunrise) offering weight management consultations.

The Florida Coverage Gap

Florida has not expanded Medicaid, leaving an estimated 800,000 residents in the coverage gap — earning too much for traditional Medicaid but too little for marketplace subsidies. For these residents, cash-pay telehealth platforms offering compounded semaglutide at $150-$400/month represent the most viable access pathway. Florida high retiree population also means Medicare coverage decisions have an outsized impact on GLP-1 access in the state.

Florida Weight Loss Clinic Market

Florida has one of the most active weight loss clinic markets in the country, driven by a large population, high aesthetic consciousness, and a year-round outdoor lifestyle. Miami, Fort Lauderdale, Tampa, and Orlando all have numerous in-person clinics prescribing GLP-1 medications. Competition among providers has helped keep cash-pay prices more competitive than in many other states. However, this also means patients should carefully vet providers for board certification and legitimate clinical practices.

Medicare and GLP-1 Access for Seniors

Florida has the largest Medicare population of any state. Medicare Part D plans have expanded GLP-1 coverage significantly, particularly after the Inflation Reduction Act capped insulin costs and the subsequent expansion to anti-obesity medications. Florida seniors enrolled in Medicare Advantage plans through Humana, UnitedHealthcare, and Aetna often have GLP-1 coverage with varying cost-sharing requirements.

  • Florida has the most Medicare beneficiaries of any state
  • Medicare Advantage plans increasingly cover GLP-1s for weight management
  • Traditional Medicare Part D covers GLP-1s for diabetes; weight management coverage expanding

Compounding in the Sunshine State

Florida Board of Pharmacy regulates a large number of compounding pharmacies, including many 503B outsourcing facilities. The state warm climate requires careful cold-chain shipping practices for injectable GLP-1 medications. Many telehealth platforms partner with Florida-based compounding facilities, meaning in-state delivery is often next-day. Compounded semaglutide starts at $150/month in Florida, among the most competitive prices nationally.

FAQ

Frequently Asked Questions

Florida has not expanded Medicaid. Traditional Medicaid covers GLP-1s only for type 2 diabetes for very limited populations (low-income parents, pregnant women, disabled individuals). Most Floridians access GLP-1s through commercial insurance or cash pay.

Compounded semaglutide through telehealth platforms starts at $150/month in Florida. This is significantly less than brand-name Wegovy at $900-$1,400/month. Florida competitive clinic market also means frequent promotions.

Yes. Florida out-of-state telehealth provider registration allows seasonal residents to access providers licensed in other states. Alternatively, Florida-licensed providers can prescribe to anyone physically in Florida during the consultation.

Yes. Miami has a dense network of weight loss clinics prescribing GLP-1 medications. Look for board-certified physicians in obesity medicine or endocrinology. Cleveland Clinic Florida in Weston and University of Miami Health are among the top academic options in South Florida.

Florida Blue (BCBS) covers Wegovy for weight management under many employer-sponsored plans with prior authorization. Coverage requires documented BMI >= 30 or >= 27 with comorbidities. Individual marketplace plans may have more limited coverage.

Ready to take control?

Start tracking your nutrition, weight, and health metrics with AI-powered insights.

Get Started Free